Author Archives: Joana Fernandes, PhD

Novel Mutations Linked to Early-onset Alzheimer’s Found in Asian Countries

Researchers reviewed the novel mutations found in genes associated with early-onset Alzheimer’s disease in Asian countries, arguing that identifying disease-associated mutations greatly contributes to the knowledge of the cause and effect of the disease. This information is also essential to develop preventive and therapeutic strategies. The study, “Mutations, Associated With Early-Onset Alzheimer’s Disease, Discovered In…

Failure of Immunotherapy in Alzheimer’s Clinical Trials May Be Due to Presence of Another Form of Dementia

Immunotherapy for Alzheimer’s disease may not provide a clinical benefit in patients that also developed vascular cognitive impairment and dementia (VCID), another form of dementia, according to a new study. The study, “Reduced Efficacy of Anti-Aβ Immunotherapy in a Mouse Model of Amyloid Deposition and Vascular Cognitive Impairment Comorbidity,”…

Potential Alzheimer’s Treatments in Growing Number of Phase 2 and Phase 3 Studies, Group Reports

The number of clinical trials evaluating possible treatments for Alzheimer’s disease is on the increase, according to a recent analysis conducted by ResearchersAgainstAlzheimer’s (RA2), a global network of Alzheimer’s researchers that is part of a non-profit organization promoting the study and treatment of this disease, called UsAgainstAlzheimer’s. The…